muscle weakness lower limb; numbness in feet/ numbness in left buttock/ numbness and tingling down left leg and numbness and cold in left foot; cold in left foot; tingling down left leg; feeling strange when walking; bp 140/92; this is a spontaneous report received from a contactable reporter(s) (pharmacist) from a regulatory authority. regulatory number: gb-mhra-webcovid-202202141306073250-wtyhq. other case identifier(s): gb-mhra-adr 26601341. a 30 year-old male patient received bnt162b2 (comirnaty), administration date 14feb2022 (batch/lot number: fm3092) at the age of 30 years as dose 1, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. unsure if patient has had symptoms associated with covid-19. patient did not have a covid-19 test. the following information was reported: muscular weakness (medically significant) with onset 14feb2022, outcome "not recovered", described as "muscle weakness lower limb"; hypoaesthesia (medically significant) with onset 14feb2022, outcome "not recovered", described as "numbness in feet/ numbness in left buttock/ numbness and tingling down left leg and numbness and cold in left foot"; peripheral coldness (non-serious) with onset 14feb2022, outcome "unknown", described as "cold in left foot"; paraesthesia (non-serious) with onset 14feb2022, outcome "unknown", described as "tingling down left leg"; feeling abnormal (non-serious) with onset 14feb2022, outcome "unknown", described as "feeling strange when walking"; blood pressure increased (non-serious) with onset 14feb2022, outcome "unknown", described as "bp 140/92". patient had first dose of vaccine and walked to the observation room and sat down. within seconds of sitting down, patient reported numbness in left buttock, numbness and tingling down left leg and numbness and cold in left foot. all observations were within normal range, no shortness of breath or chest signs. patient reported feeling strange when walking. no double vision reported. the patient underwent the following laboratory tests and procedures: blood glucose: (14feb2022) 5.6; blood pressure measurement: (14feb2022) 140/92; body temperature: (14feb2022) 36.2 centigrade; heart rate: (14feb2022) 84, notes: bpm; oxygen saturation: (14feb2022) 99 %. patient has not tested positive for covid-19 since having the vaccine. unsure if patient is enrolled in clinical trial. the report didn't relate to possible blood clots or low platelet counts. the report didn't relate to possible myocarditis or pericarditis. no follow-up attempts are possible. no further information is expected

test date: 20220214; test name: blood glucose; result unstructured data: test result:5.6; test date: 20220214; test name: blood pressure; result unstructured data: test result:140/92; test date: 20220214; test name: body temperature; result unstructured data: test result:36.2 centigrade; test date: 20220214; test name: pulse rate; result unstructured data: test result:84; comments: bpm; test date: 20220214; test name: o2 saturation; test result: 99 %

na

na